IP Library Granted Patent US 12,054,791
Granted Patent B2
US 12,054,791 · App. 17/171,951 · Granted Aug 6, 2024

Pathogen and antimicrobial resistance testing

Inventors: Elizabeth A. Holmes (San Francisco, CA); Chandan Shee (Newark, CA); Clarissa Lui (Menlo Park, CA)
Assignee: Labrador Diagnostics LLC
C12Q1/689C12Q1/04G01N33/53G01N33/56911C12Q2600/156C12Q2600/158G01N2469/10G01N2469/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,054,791
App. No.
17/171,951
Granted
Aug 6, 2024
Kind
B2
Abstract

Systems and methods for determining pathogens and antimicrobial resistance of pathogens in a sample are provided.

Claims (36)

1. A method for analysis of a sample, the method comprising:

receiving a cartridge in a sample processing device, wherein the sample processing device comprises a fluid handling system, and wherein the cartridge comprises:

a sample,

an antimicrobial,

a microorganism growth medium, and

a reagent for a nucleic acid amplification reaction;

transferring, by the fluid handling system, a first portion of the sample from a first region of the cartridge to a second region of the cartridge in fluid communication with the reagent for the nucleic acid amplification reaction, to generate a first mixture comprising the first portion of the sample and the reagent for the nucleic acid amplification reaction;

transferring, by the fluid handling system, a second portion of the sample from the first region of the cartridge to a third region of the cartridge fluid communication with the antimicrobial and the microorganism growth medium, to generate a second mixture comprising the second portion of the sample, the antimicrobial, and the microorganism growth medium;

incubating the first mixture under conditions sufficient to support the amplification of a nucleic acid of the pathogen in the sample;

culturing the second mixture under conditions sufficient to support growth of the pathogen in the second mixture;

detecting amplification of the nucleic acid from the pathogen in the sample; and

detecting growth of the pathogen in the sample.

2. The method of claim 1 , wherein detecting amplification of the nucleic acid from the pathogen in the sample comprises detecting fluorescence from a dye in the first mixture.

3. The method of claim 1 , wherein the detecting amplification of the nucleic acid from the pathogen in the sample and the detecting of the growth of the pathogen in the sample both occur no more than 24 hours after the cartridge is received in the sample processing device.

4. A method for analysis of a sample, the method comprising:

receiving a cartridge in a sample processing device, wherein the sample processing device comprises a fluid handling system, and wherein the cartridge comprises:

a sample,

an antimicrobial,

a microorganism growth medium; and

a nucleic acid probe capable of specifically hybridizing to a nucleic acid, or a complement thereof, of the pathogen;

transferring, by the fluid handling system, a first portion of the sample from a first region of the cartridge to a second region of the cartridge in fluid communication with the nucleic acid probe, to generate a first mixture comprising the first portion of the sample and the nucleic acid probe;

transferring, by the fluid handling system, a second portion of the sample from the first region of the cartridge to a third region of the cartridge in fluid communication with the antimicrobial and the microorganism growth medium, to generate a second mixture comprising the second portion of the sample, the antimicrobial, and the microorganism growth medium;

incubating the first mixture under conditions sufficient to specifically hybridize to a nucleic acid, or a complement thereof, of the pathogen in the sample;

culturing the second mixture under conditions sufficient to support growth of the pathogen;

detecting the nucleic acid of the pathogen in the sample; and

detecting growth of the pathogen in the sample.

5. The method of claim 4 , wherein detecting growth of the pathogen in the sample comprises examining the second mixture with a cytometer.

6. The method of claim 5 , wherein examining comprises counting the number of pathogen cells.

7. The method of claim 5 , wherein examining comprises detecting an antigen of the pathogen.

8. The method of claim 5 , wherein examining comprises determining a ratio or number of pathogen cells undergoing cell division.

9. The method of claim 4 , wherein detecting growth of the pathogen in the sample comprises examining the second mixture with a spectrophotometer.

10. The method of claim 9 , wherein examining comprises determining the optical density of the second mixture.

11. The method of claim 10 , wherein the method comprises:

transferring, by the fluid handling system, the second portion of the sample into fluid communication with the antimicrobial, the microorganism growth medium, and a metabolic indicator, configured to be metabolized to produce a metabolic product, to generate a second mixture comprising the second portion of the sample, the antimicrobial, the microorganism growth medium, and the metabolic indicator.

12. The method of claim 11 , wherein the metabolic indicator is selected from resazurin, 5-cyano-2,3-ditolyl tetrazolium chloride (CTC), carboxyfluorescein diacetate succinimidyl ester (CFDA-SE), and luciferin.

13. The method of claim 12 , wherein the metabolic indicator is resazurin.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2021
From: HOLMES, ELIZABETH; SHEE, CHANDAN; LUI, CLARISSA
To: THERANOS, INC.
Reel/Frame 055204/0650 →
CHANGE OF NAME Recorded Feb 9, 2021
From: THERANOS IP COMPANY, LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 055266/0501 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2021
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 055266/0518 →
Continuity (5)
Continuation 15159399 · May 19, 2016
Continuation PCTUS2015048533 · Sep 4, 2015
Provisional Application 62046135 · Sep 4, 2014
Provisional Application 62061093 · Oct 7, 2014
Related Publication 20210269859A1 · Sep 2, 2021